Clinical Trial Update: Safety Study of PZ-128 in Subjects With Multiple Coronary Artery Disease Risk Factors [Phase 1]

View source ↗

Summary

Phase 1 safety study of PZ-128 in subjects with multiple risk factors for coronary artery disease conducted by Tufts Medical Center; the trial is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Vascular Disease

Drugs mentioned

• PZ-128

Snippet

Sponsor: Tufts Medical Center | Conditions: Vascular Disease, Coronary Artery Disease Risk Factors Multiple | Phase 1 | Status: COMPLETED